The spread of measles raises concerns among some cancer patients, and a treatment for early-stage HER2-positive breast cancer is approved by the U.S. Food and Drug Administration.

by Kate Yandell and Bradley Jones

Prospective CRISPR application targets cancer directly, HER2 testing accessibility poor in many countries.

by Bradley Jones

A study indicates that the majority of patients using immune checkpoint inhibitors experience side effects, and radiation oncologists say that requirements for prior authorization are impeding care.

by Kate Yandell

The CRISPR gene-editing technique is used for the first time in a U.S. cancer clinical trial, and a new targeted therapy is approved for advanced bladder cancer.

by Kate Yandell

Cancer patients report difficulty getting student loans deferred, and new guidelines for breast cancer screening are released.

by Kate Yandell

People with metastatic cancer call for more research into survivorship issues facing this group, and a study indicates that taking probiotics may interfere with immunotherapy response.

by Marci A. Landsmann and Kate Yandell

Jury awards damages to man who says Roundup caused his cancer, the FDA proposes national standards for breast density notifications, and a physician questions whether patients with impaired renal function should avoid contrast-enhanced scans.

by Marci A. Landsmann

A study suggests that 3-D mammograms may reduce unnecessary biopsies, and the U.S. Food and Drug Administration issues warnings to breast implant companies.

by Kate Yandell

NCI director steps in as FDA commissioner, new guidelines on clinical trial eligibility, and health risks for childhood cancer survivors.

by Bradley Jones

FDA Commissioner Scott Gottlieb resigns, an analysis explores patient advocacy groups' financial ties, and Alex Trebek announces he has pancreatic cancer.

by Marci A. Landsmann